Make Sure Patients With Heavy Alcohol Use Don't Take Viberzi

June 2016

You'll see a flood of ads for Viberzi (vye-BUR-zee, eluxadoline), a new Rx drug for irritable bowel syndrome with diarrhea (IBS-D).

IBS-D is hard to treat...management can be more art than science.

Viberzi is an opioid agonist that works primarily in the gut...similar to loperamide (Imodium A-D, etc).

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Cardiology Consider the New DAPT Score to Balance Ischemia vs Bleeding in Stent Patients
Dyslipidemia Don't Add Niacin or Fibrates for Most Statin Patients
Gastroenterology Make Sure Patients With Heavy Alcohol Use Don't Take Viberzi
Diabetes Feel Comfortable Using Metformin in More Diabetes Patients With Kidney Disease
Diabetes Lean Away From using Gliptins in Heart Failure
Pediatrics Consider Recent Antibiotic Use When Treating Children With a UTI
Cardiology Use an ACEI or ARB Instead of Aliskiren (Tekturna)
Infectious Diseases Consider Antibiotics a Suspect for Causing CNS Effects
Neurology & Pain Consider Topical Analgesics for Pain...to Spare Opioids and Oral NSAIDs
Rheumatology Consider More Frequent Fine-Tuning of Rheumatoid Arthritis Meds
Women's Health Avoid Even One Dose of Fluconazole in Pregnant Women
Practice link between aripiprazole (Abilify, etc) and a higher risk of impulse-control behaviors
Medication Errors Prescribe Generic Vortioxetine...To Avoid Brintellix and Trintellix Mix-Ups
Cardiology Stop Postop Atrial Fib Meds 4 Weeks After Sinus Rhythm Returns In Most Patients